InvestorsHub Logo
icon url

jour_trader

10/20/18 11:23 PM

#302166 RE: NASDAQ2020 #302165

IMO, if results were significant, the study would have been halted. I think results will be modest, at very best, leaving patients wonder if Isradipine is worth the incremental cost.